Cardiac arrhythmia during propofol sedation

Area of Science:

• Emergency Medicine
• Cardiology
• Pharmacology

Background:

• Propofol is increasingly used for procedural sedation in emergency departments (EDs).
• Existing literature often highlights propofol's favorable safety profile in ED settings.
• This case report addresses a potential, serious adverse cardiac event associated with propofol use.

Observation:

• A patient undergoing propofol sedation for tibia and fibula fracture reduction experienced cardiac complications.
• The patient developed torsade de pointes, a polymorphic ventricular tachycardia.
• This progressed to ventricular fibrillation, a life-threatening arrhythmia.

Findings:

• The adverse cardiac event occurred during propofol administration for procedural sedation.
• The specific mechanism linking propofol to this event in this context requires further investigation.
• This case highlights a rare but critical risk associated with propofol sedation.

Implications:

• Clinicians should be aware of the potential for severe cardiac arrhythmias with propofol sedation, even in otherwise healthy patients.
• Further research is warranted to elucidate the pathophysiology and identify risk factors for propofol-induced cardiac events.
• Enhanced monitoring protocols may be considered for patients receiving propofol for procedural sedation, particularly in the ED.